Global Diabetes Management Devices Market Insights and Forecast to 2026

Publisher Name :
Date: 15-Jul-2020
No. of pages: 185
Inquire Before Buying

Diabetes Management Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Management Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Diabetes Management Devices market is segmented into

- Blood glucose monitoring device

- Insulin delivery systems

Segment by Application, the Diabetes Management Devices market is segmented into

- Hospitals

- Clinics and laboratories

- Others

Regional and Country-level Analysis

The Diabetes Management Devices market is analysed and market size information is provided by regions (countries).

The key regions covered in the Diabetes Management Devices market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.

Competitive Landscape and Diabetes Management Devices Market Share Analysis

Diabetes Management Devices market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Diabetes Management Devices by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Diabetes Management Devices business, the date to enter into the Diabetes Management Devices market, Diabetes Management Devices product introduction, recent developments, etc.

The major vendors covered:

- Abbott

- Dexcom

- F. Hoffmann-La Roche

- LifeScan

- Medtronic

- AgaMatrix

- Animas

- ARKRAY

- Ascensia Diabetes Care

- B. Braun Melsungen

- BD

- Beta Bionics

- Bigfoot Biomedical

- BIONIME USA

- CellNovo

- Eli Lilly

- iHealth Labs

- Insulet

- Nemaura Medical

- Nipro

- Nova Biomedical

- Novo Nordisk

- Panasonic Healthcare

- Prodigy Diabetes Care

- Sanofi

- Senseonics

- Tandem Diabetes Care

- Trividia Health

- TypeZero Technologies

- Valeritas

Global Diabetes Management Devices Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Diabetes Management Devices Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Diabetes Management Devices Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Diabetes Management Devices Market Size Growth Rate by Type
1.4.2 Blood glucose monitoring device
1.4.3 Insulin delivery systems
1.5 Market by Application
1.5.1 Global Diabetes Management Devices Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics and laboratories
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Diabetes Management Devices Market Size, Estimates and Forecasts
2.1.1 Global Diabetes Management Devices Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Diabetes Management Devices Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Diabetes Management Devices Production Estimates and Forecasts 2015-2026
2.2 Global Diabetes Management Devices, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Diabetes Management Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Diabetes Management Devices Manufacturers Geographical Distribution
2.4 Key Trends for Diabetes Management Devices Markets & Products
2.5 Primary Interviews with Key Diabetes Management Devices Players (Opinion Leaders)
3 Market Size by Manufacturers
3.1 Global Top Diabetes Management Devices Manufacturers by Production Capacity
3.1.1 Global Top Diabetes Management Devices Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Diabetes Management Devices Manufacturers by Production (2015-2020)
3.1.3 Global Top Diabetes Management Devices Manufacturers Market Share by Production
3.2 Global Top Diabetes Management Devices Manufacturers by Revenue
3.2.1 Global Top Diabetes Management Devices Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Diabetes Management Devices Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Diabetes Management Devices Revenue in 2019
3.3 Global Diabetes Management Devices Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 Diabetes Management Devices Production by Regions
4.1 Global Diabetes Management Devices Historic Market Facts & Figures by Regions
4.1.1 Global Top Diabetes Management Devices Regions by Production (2015-2020)
4.1.2 Global Top Diabetes Management Devices Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Diabetes Management Devices Production (2015-2020)
4.2.2 North America Diabetes Management Devices Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Diabetes Management Devices Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Diabetes Management Devices Production (2015-2020)
4.3.2 Europe Diabetes Management Devices Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Diabetes Management Devices Import & Export (2015-2020)
4.4 China
4.4.1 China Diabetes Management Devices Production (2015-2020)
4.4.2 China Diabetes Management Devices Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Diabetes Management Devices Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Diabetes Management Devices Production (2015-2020)
4.5.2 Japan Diabetes Management Devices Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Diabetes Management Devices Import & Export (2015-2020)
5 Diabetes Management Devices Consumption by Region
5.1 Global Top Diabetes Management Devices Regions by Consumption
5.1.1 Global Top Diabetes Management Devices Regions by Consumption (2015-2020)
5.1.2 Global Top Diabetes Management Devices Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Diabetes Management Devices Consumption by Application
5.2.2 North America Diabetes Management Devices Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Diabetes Management Devices Consumption by Application
5.3.2 Europe Diabetes Management Devices Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Diabetes Management Devices Consumption by Application
5.4.2 Asia Pacific Diabetes Management Devices Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Diabetes Management Devices Consumption by Application
5.5.2 Central & South America Diabetes Management Devices Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Diabetes Management Devices Consumption by Application
5.6.2 Middle East and Africa Diabetes Management Devices Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 Market Size by Type (2015-2026)
6.1 Global Diabetes Management Devices Market Size by Type (2015-2020)
6.1.1 Global Diabetes Management Devices Production by Type (2015-2020)
6.1.2 Global Diabetes Management Devices Revenue by Type (2015-2020)
6.1.3 Diabetes Management Devices Price by Type (2015-2020)
6.2 Global Diabetes Management Devices Market Forecast by Type (2021-2026)
6.2.1 Global Diabetes Management Devices Production Forecast by Type (2021-2026)
6.2.2 Global Diabetes Management Devices Revenue Forecast by Type (2021-2026)
6.2.3 Global Diabetes Management Devices Price Forecast by Type (2021-2026)
6.3 Global Diabetes Management Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 Market Size by Application (2015-2026)
7.2.1 Global Diabetes Management Devices Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Diabetes Management Devices Consumption Forecast by Application (2021-2026)
8 Corporate Profiles
8.1 Abbott
8.1.1 Abbott Corporation Information
8.1.2 Abbott Overview
8.1.3 Abbott Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Abbott Product Description
8.1.5 Abbott Related Developments
8.2 Dexcom
8.2.1 Dexcom Corporation Information
8.2.2 Dexcom Overview
8.2.3 Dexcom Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Dexcom Product Description
8.2.5 Dexcom Related Developments
8.3 F. Hoffmann-La Roche
8.3.1 F. Hoffmann-La Roche Corporation Information
8.3.2 F. Hoffmann-La Roche Overview
8.3.3 F. Hoffmann-La Roche Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 F. Hoffmann-La Roche Product Description
8.3.5 F. Hoffmann-La Roche Related Developments
8.4 LifeScan
8.4.1 LifeScan Corporation Information
8.4.2 LifeScan Overview
8.4.3 LifeScan Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 LifeScan Product Description
8.4.5 LifeScan Related Developments
8.5 Medtronic
8.5.1 Medtronic Corporation Information
8.5.2 Medtronic Overview
8.5.3 Medtronic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Medtronic Product Description
8.5.5 Medtronic Related Developments
8.6 AgaMatrix
8.6.1 AgaMatrix Corporation Information
8.6.2 AgaMatrix Overview
8.6.3 AgaMatrix Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 AgaMatrix Product Description
8.6.5 AgaMatrix Related Developments
8.7 Animas
8.7.1 Animas Corporation Information
8.7.2 Animas Overview
8.7.3 Animas Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Animas Product Description
8.7.5 Animas Related Developments
8.8 ARKRAY
8.8.1 ARKRAY Corporation Information
8.8.2 ARKRAY Overview
8.8.3 ARKRAY Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 ARKRAY Product Description
8.8.5 ARKRAY Related Developments
8.9 Ascensia Diabetes Care
8.9.1 Ascensia Diabetes Care Corporation Information
8.9.2 Ascensia Diabetes Care Overview
8.9.3 Ascensia Diabetes Care Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Ascensia Diabetes Care Product Description
8.9.5 Ascensia Diabetes Care Related Developments
8.10 B. Braun Melsungen
8.10.1 B. Braun Melsungen Corporation Information
8.10.2 B. Braun Melsungen Overview
8.10.3 B. Braun Melsungen Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 B. Braun Melsungen Product Description
8.10.5 B. Braun Melsungen Related Developments
8.11 BD
8.11.1 BD Corporation Information
8.11.2 BD Overview
8.11.3 BD Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 BD Product Description
8.11.5 BD Related Developments
8.12 Beta Bionics
8.12.1 Beta Bionics Corporation Information
8.12.2 Beta Bionics Overview
8.12.3 Beta Bionics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Beta Bionics Product Description
8.12.5 Beta Bionics Related Developments
8.13 Bigfoot Biomedical
8.13.1 Bigfoot Biomedical Corporation Information
8.13.2 Bigfoot Biomedical Overview
8.13.3 Bigfoot Biomedical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 Bigfoot Biomedical Product Description
8.13.5 Bigfoot Biomedical Related Developments
8.14 BIONIME USA
8.14.1 BIONIME USA Corporation Information
8.14.2 BIONIME USA Overview
8.14.3 BIONIME USA Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.14.4 BIONIME USA Product Description
8.14.5 BIONIME USA Related Developments
8.15 CellNovo
8.15.1 CellNovo Corporation Information
8.15.2 CellNovo Overview
8.15.3 CellNovo Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.15.4 CellNovo Product Description
8.15.5 CellNovo Related Developments
8.16 Eli Lilly
8.16.1 Eli Lilly Corporation Information
8.16.2 Eli Lilly Overview
8.16.3 Eli Lilly Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.16.4 Eli Lilly Product Description
8.16.5 Eli Lilly Related Developments
8.17 iHealth Labs
8.17.1 iHealth Labs Corporation Information
8.17.2 iHealth Labs Overview
8.17.3 iHealth Labs Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.17.4 iHealth Labs Product Description
8.17.5 iHealth Labs Related Developments
8.18 Insulet
8.18.1 Insulet Corporation Information
8.18.2 Insulet Overview
8.18.3 Insulet Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.18.4 Insulet Product Description
8.18.5 Insulet Related Developments
8.19 Nemaura Medical
8.19.1 Nemaura Medical Corporation Information
8.19.2 Nemaura Medical Overview
8.19.3 Nemaura Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.19.4 Nemaura Medical Product Description
8.19.5 Nemaura Medical Related Developments
8.20 Nipro
8.20.1 Nipro Corporation Information
8.20.2 Nipro Overview
8.20.3 Nipro Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.20.4 Nipro Product Description
8.20.5 Nipro Related Developments
8.21 Nova Biomedical
8.21.1 Nova Biomedical Corporation Information
8.21.2 Nova Biomedical Overview
8.21.3 Nova Biomedical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.21.4 Nova Biomedical Product Description
8.21.5 Nova Biomedical Related Developments
8.22 Novo Nordisk
8.22.1 Novo Nordisk Corporation Information
8.22.2 Novo Nordisk Overview
8.22.3 Novo Nordisk Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.22.4 Novo Nordisk Product Description
8.22.5 Novo Nordisk Related Developments
8.23 Panasonic Healthcare
8.23.1 Panasonic Healthcare Corporation Information
8.23.2 Panasonic Healthcare Overview
8.23.3 Panasonic Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.23.4 Panasonic Healthcare Product Description
8.23.5 Panasonic Healthcare Related Developments
8.24 Prodigy Diabetes Care
8.24.1 Prodigy Diabetes Care Corporation Information
8.24.2 Prodigy Diabetes Care Overview
8.24.3 Prodigy Diabetes Care Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.24.4 Prodigy Diabetes Care Product Description
8.24.5 Prodigy Diabetes Care Related Developments
8.25 Sanofi
8.25.1 Sanofi Corporation Information
8.25.2 Sanofi Overview
8.25.3 Sanofi Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.25.4 Sanofi Product Description
8.25.5 Sanofi Related Developments
8.26 Senseonics
8.26.1 Senseonics Corporation Information
8.26.2 Senseonics Overview
8.26.3 Senseonics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.26.4 Senseonics Product Description
8.26.5 Senseonics Related Developments
8.27 Tandem Diabetes Care
8.27.1 Tandem Diabetes Care Corporation Information
8.27.2 Tandem Diabetes Care Overview
8.27.3 Tandem Diabetes Care Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.27.4 Tandem Diabetes Care Product Description
8.27.5 Tandem Diabetes Care Related Developments
8.28 Trividia Health
8.28.1 Trividia Health Corporation Information
8.28.2 Trividia Health Overview
8.28.3 Trividia Health Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.28.4 Trividia Health Product Description
8.28.5 Trividia Health Related Developments
8.29 TypeZero Technologies
8.29.1 TypeZero Technologies Corporation Information
8.29.2 TypeZero Technologies Overview
8.29.3 TypeZero Technologies Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.29.4 TypeZero Technologies Product Description
8.29.5 TypeZero Technologies Related Developments
8.30 Valeritas
8.30.1 Valeritas Corporation Information
8.30.2 Valeritas Overview
8.30.3 Valeritas Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.30.4 Valeritas Product Description
8.30.5 Valeritas Related Developments
9 Diabetes Management Devices Production Forecast by Regions
9.1 Global Top Diabetes Management Devices Regions Forecast by Revenue (2021-2026)
9.2 Global Top Diabetes Management Devices Regions Forecast by Production (2021-2026)
9.3 Key Diabetes Management Devices Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 Diabetes Management Devices Consumption Forecast by Region
10.1 Global Diabetes Management Devices Consumption Forecast by Region (2021-2026)
10.2 North America Diabetes Management Devices Consumption Forecast by Region (2021-2026)
10.3 Europe Diabetes Management Devices Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Diabetes Management Devices Consumption Forecast by Region (2021-2026)
10.5 Latin America Diabetes Management Devices Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Diabetes Management Devices Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Diabetes Management Devices Sales Channels
11.2.2 Diabetes Management Devices Distributors
11.3 Diabetes Management Devices Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
12.1 Diabetes Management Devices Industry
12.2 Market Trends
12.3 Market Opportunities and Drivers
12.4 Market Challenges
12.5 Diabetes Management Devices Market Risks/Restraints
12.6 Porter's Five Forces Analysis
13 Key Finding in The Global Diabetes Management Devices Study
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Diabetes Management Devices Key Market Segments in This Study
Table 2. Ranking of Global Top Diabetes Management Devices Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Diabetes Management Devices Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Blood glucose monitoring device
Table 5. Major Manufacturers of Insulin delivery systems
Table 6. Global Diabetes Management Devices Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Diabetes Management Devices Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 8. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 9. Global Diabetes Management Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Management Devices as of 2019)
Table 10. Diabetes Management Devices Manufacturing Base Distribution and Headquarters
Table 11. Manufacturers Diabetes Management Devices Product Offered
Table 12. Date of Manufacturers Enter into Diabetes Management Devices Market
Table 13. Key Trends for Diabetes Management Devices Markets & Products
Table 14. Main Points Interviewed from Key Diabetes Management Devices Players
Table 15. Global Diabetes Management Devices Production Capacity by Manufacturers (2015-2020) (K Units)
Table 16. Global Diabetes Management Devices Production Share by Manufacturers (2015-2020)
Table 17. Diabetes Management Devices Revenue by Manufacturers (2015-2020) (Million US$)
Table 18. Diabetes Management Devices Revenue Share by Manufacturers (2015-2020)
Table 19. Diabetes Management Devices Price by Manufacturers 2015-2020 (USD/Unit)
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global Diabetes Management Devices Production by Regions (2015-2020) (K Units)
Table 22. Global Diabetes Management Devices Production Market Share by Regions (2015-2020)
Table 23. Global Diabetes Management Devices Revenue by Regions (2015-2020) (US$ Million)
Table 24. Global Diabetes Management Devices Revenue Market Share by Regions (2015-2020)
Table 25. Key Diabetes Management Devices Players in North America
Table 26. Import & Export of Diabetes Management Devices in North America (K Units)
Table 27. Key Diabetes Management Devices Players in Europe
Table 28. Import & Export of Diabetes Management Devices in Europe (K Units)
Table 29. Key Diabetes Management Devices Players in China
Table 30. Import & Export of Diabetes Management Devices in China (K Units)
Table 31. Key Diabetes Management Devices Players in Japan
Table 32. Import & Export of Diabetes Management Devices in Japan (K Units)
Table 33. Global Diabetes Management Devices Consumption by Regions (2015-2020) (K Units)
Table 34. Global Diabetes Management Devices Consumption Market Share by Regions (2015-2020)
Table 35. North America Diabetes Management Devices Consumption by Application (2015-2020) (K Units)
Table 36. North America Diabetes Management Devices Consumption by Countries (2015-2020) (K Units)
Table 37. Europe Diabetes Management Devices Consumption by Application (2015-2020) (K Units)
Table 38. Europe Diabetes Management Devices Consumption by Countries (2015-2020) (K Units)
Table 39. Asia Pacific Diabetes Management Devices Consumption by Application (2015-2020) (K Units)
Table 40. Asia Pacific Diabetes Management Devices Consumption Market Share by Application (2015-2020) (K Units)
Table 41. Asia Pacific Diabetes Management Devices Consumption by Regions (2015-2020) (K Units)
Table 42. Latin America Diabetes Management Devices Consumption by Application (2015-2020) (K Units)
Table 43. Latin America Diabetes Management Devices Consumption by Countries (2015-2020) (K Units)
Table 44. Middle East and Africa Diabetes Management Devices Consumption by Application (2015-2020) (K Units)
Table 45. Middle East and Africa Diabetes Management Devices Consumption by Countries (2015-2020) (K Units)
Table 46. Global Diabetes Management Devices Production by Type (2015-2020) (K Units)
Table 47. Global Diabetes Management Devices Production Share by Type (2015-2020)
Table 48. Global Diabetes Management Devices Revenue by Type (2015-2020) (Million US$)
Table 49. Global Diabetes Management Devices Revenue Share by Type (2015-2020)
Table 50. Diabetes Management Devices Price by Type 2015-2020 (USD/Unit)
Table 51. Global Diabetes Management Devices Consumption by Application (2015-2020) (K Units)
Table 52. Global Diabetes Management Devices Consumption Share by Application (2015-2020)
Table 53. Abbott Corporation Information
Table 54. Abbott Description and Major Businesses
Table 55. Abbott Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Abbott Product
Table 57. Abbott Recent Development
Table 58. Dexcom Corporation Information
Table 59. Dexcom Description and Major Businesses
Table 60. Dexcom Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Dexcom Product
Table 62. Dexcom Recent Development
Table 63. F. Hoffmann-La Roche Corporation Information
Table 64. F. Hoffmann-La Roche Description and Major Businesses
Table 65. F. Hoffmann-La Roche Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. F. Hoffmann-La Roche Product
Table 67. F. Hoffmann-La Roche Recent Development
Table 68. LifeScan Corporation Information
Table 69. LifeScan Description and Major Businesses
Table 70. LifeScan Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. LifeScan Product
Table 72. LifeScan Recent Development
Table 73. Medtronic Corporation Information
Table 74. Medtronic Description and Major Businesses
Table 75. Medtronic Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Medtronic Product
Table 77. Medtronic Recent Development
Table 78. AgaMatrix Corporation Information
Table 79. AgaMatrix Description and Major Businesses
Table 80. AgaMatrix Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. AgaMatrix Product
Table 82. AgaMatrix Recent Development
Table 83. Animas Corporation Information
Table 84. Animas Description and Major Businesses
Table 85. Animas Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Animas Product
Table 87. Animas Recent Development
Table 88. ARKRAY Corporation Information
Table 89. ARKRAY Description and Major Businesses
Table 90. ARKRAY Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. ARKRAY Product
Table 92. ARKRAY Recent Development
Table 93. Ascensia Diabetes Care Corporation Information
Table 94. Ascensia Diabetes Care Description and Major Businesses
Table 95. Ascensia Diabetes Care Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Ascensia Diabetes Care Product
Table 97. Ascensia Diabetes Care Recent Development
Table 98. B. Braun Melsungen Corporation Information
Table 99. B. Braun Melsungen Description and Major Businesses
Table 100. B. Braun Melsungen Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. B. Braun Melsungen Product
Table 102. B. Braun Melsungen Recent Development
Table 103. BD Corporation Information
Table 104. BD Description and Major Businesses
Table 105. BD Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. BD Product
Table 107. BD Recent Development
Table 108. Beta Bionics Corporation Information
Table 109. Beta Bionics Description and Major Businesses
Table 110. Beta Bionics Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Beta Bionics Product
Table 112. Beta Bionics Recent Development
Table 113. Bigfoot Biomedical Corporation Information
Table 114. Bigfoot Biomedical Description and Major Businesses
Table 115. Bigfoot Biomedical Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Bigfoot Biomedical Product
Table 117. Bigfoot Biomedical Recent Development
Table 118. BIONIME USA Corporation Information
Table 119. BIONIME USA Description and Major Businesses
Table 120. BIONIME USA Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. BIONIME USA Product
Table 122. BIONIME USA Recent Development
Table 123. CellNovo Corporation Information
Table 124. CellNovo Description and Major Businesses
Table 125. CellNovo Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. CellNovo Product
Table 127. CellNovo Recent Development
Table 128. Eli Lilly Corporation Information
Table 129. Eli Lilly Description and Major Businesses
Table 130. Eli Lilly Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 131. Eli Lilly Product
Table 132. Eli Lilly Recent Development
Table 133. iHealth Labs Corporation Information
Table 134. iHealth Labs Description and Major Businesses
Table 135. iHealth Labs Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 136. iHealth Labs Product
Table 137. iHealth Labs Recent Development
Table 138. Insulet Corporation Information
Table 139. Insulet Description and Major Businesses
Table 140. Insulet Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 141. Insulet Product
Table 142. Insulet Recent Development
Table 143. Nemaura Medical Corporation Information
Table 144. Nemaura Medical Description and Major Businesses
Table 145. Nemaura Medical Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 146. Nemaura Medical Product
Table 147. Nemaura Medical Recent Development
Table 148. Nipro Corporation Information
Table 149. Nipro Description and Major Businesses
Table 150. Nipro Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 151. Nipro Product
Table 152. Nipro Recent Development
Table 153. Nova Biomedical Corporation Information
Table 154. Nova Biomedical Description and Major Businesses
Table 155. Nova Biomedical Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 156. Nova Biomedical Product
Table 157. Nova Biomedical Recent Development
Table 158. Novo Nordisk Corporation Information
Table 159. Novo Nordisk Description and Major Businesses
Table 160. Novo Nordisk Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 161. Novo Nordisk Product
Table 162. Novo Nordisk Recent Development
Table 163. Panasonic Healthcare Corporation Information
Table 164. Panasonic Healthcare Description and Major Businesses
Table 165. Panasonic Healthcare Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 166. Panasonic Healthcare Product
Table 167. Panasonic Healthcare Recent Development
Table 168. Prodigy Diabetes Care Corporation Information
Table 169. Prodigy Diabetes Care Description and Major Businesses
Table 170. Prodigy Diabetes Care Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 171. Prodigy Diabetes Care Product
Table 172. Prodigy Diabetes Care Recent Development
Table 173. Sanofi Corporation Information
Table 174. Sanofi Description and Major Businesses
Table 175. Sanofi Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 176. Sanofi Product
Table 177. Sanofi Recent Development
Table 178. Senseonics Corporation Information
Table 179. Senseonics Description and Major Businesses
Table 180. Senseonics Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 181. Senseonics Product
Table 182. Senseonics Recent Development
Table 183. Tandem Diabetes Care Corporation Information
Table 184. Tandem Diabetes Care Description and Major Businesses
Table 185. Tandem Diabetes Care Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 186. Tandem Diabetes Care Product
Table 187. Tandem Diabetes Care Recent Development
Table 188. Trividia Health Corporation Information
Table 189. Trividia Health Description and Major Businesses
Table 190. Trividia Health Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 191. Trividia Health Product
Table 192. Trividia Health Recent Development
Table 193. TypeZero Technologies Corporation Information
Table 194. TypeZero Technologies Description and Major Businesses
Table 195. TypeZero Technologies Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 196. TypeZero Technologies Product
Table 197. TypeZero Technologies Recent Development
Table 198. Valeritas Corporation Information
Table 199. Valeritas Description and Major Businesses
Table 200. Valeritas Diabetes Management Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 201. Valeritas Product
Table 202. Valeritas Recent Development
Table 203. Global Diabetes Management Devices Revenue Forecast by Region (2021-2026) (Million US$)
Table 204. Global Diabetes Management Devices Production Forecast by Regions (2021-2026) (K Units)
Table 205. Global Diabetes Management Devices Production Forecast by Type (2021-2026) (K Units)
Table 206. Global Diabetes Management Devices Revenue Forecast by Type (2021-2026) (Million US$)
Table 207. North America Diabetes Management Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 208. Europe Diabetes Management Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 209. Asia Pacific Diabetes Management Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 210. Latin America Diabetes Management Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 211. Middle East and Africa Diabetes Management Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 212. Diabetes Management Devices Distributors List
Table 213. Diabetes Management Devices Customers List
Table 214. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 215. Key Challenges
Table 216. Market Risks
Table 217. Research Programs/Design for This Report
Table 218. Key Data Information from Secondary Sources
Table 219. Key Data Information from Primary Sources
List of Figures
Figure 1. Diabetes Management Devices Product Picture
Figure 2. Global Diabetes Management Devices Production Market Share by Type in 2020 & 2026
Figure 3. Blood glucose monitoring device Product Picture
Figure 4. Insulin delivery systems Product Picture
Figure 5. Global Diabetes Management Devices Consumption Market Share by Application in 2020 & 2026
Figure 6. Hospitals
Figure 7. Clinics and laboratories
Figure 8. Others
Figure 9. Diabetes Management Devices Report Years Considered
Figure 10. Global Diabetes Management Devices Revenue 2015-2026 (Million US$)
Figure 11. Global Diabetes Management Devices Production Capacity 2015-2026 (K Units)
Figure 12. Global Diabetes Management Devices Production 2015-2026 (K Units)
Figure 13. Global Diabetes Management Devices Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 14. Diabetes Management Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global Diabetes Management Devices Production
  • Global Non-Invasive Glucose Meter Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 79
    This report studies The Non-Invasive Glucose Meter market. Noninvasive glucose monitoring refers to The measurement of blood glucose levels (required by people with diabetes to prevent both chronic and acute complications from The disease) without drawing blood, puncturing The skin, or causing pain or trauma. The global Non-Invasive Glucose Meter market was valued at US$ 179.5 million in 2023 and is anticipated to reach US$ 271.2 million by 2030, witnessing a CAGR of 6.0% during The......
  • Global Glucose Meter Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 106
    Glucose Meter is a medical device for determining The approximate concentration of glucose in The blood. It can also be a strip of glucose paper dipped into a substance and measured to The glucose chart. It is a key element of home blood glucose monitoring (HBGM) by people with diabetes mellitus or hypoglycemia. A small drop of blood, obtained by pricking The skin with a lancet, is placed on a disposable test strip that The meter reads and uses to calculate The blood glucose level. The meter the......
  • Global Blood Glucose Testing Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 101
    Blood glucose testing, also known as blood glucose monitoring, is one of The main tools involved in controlling diabetes. Blood glucose testing is The process used to measure The concentration of glucose in your blood. Blood glucose testing can be carried out at home using a blood glucose meter. A blood test involves pricking your finger with a small needle called a lancet, drawing a drop of blood from The finger and applying it to a test strip that has been engaged into a blood gluc......
  • Global Glucose Biosensors Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 139
    According to our LPI (LP Information) latest study, the global Glucose Biosensors market size was valued at US$ 3249.7 million in 2023. With growing demand in downstream market, the Glucose Biosensors is forecast to a readjusted size of US$ 3620.7 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Glucose Biosensors market. Glucose Biosensors are expected to show stable growth in the future market. However, product ......
  • Global Artificial Pancreas Devices Systems Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Artificial Pancreas Devices Systems market size was valued at US$ 87 million in 2023. With growing demand in downstream market, the Artificial Pancreas Devices Systems is forecast to a readjusted size of US$ 199.2 million by 2030 with a CAGR of 12.6% during review period. The research report highlights the growth potential of the global Artificial Pancreas Devices Systems market. Artificial Pancreas Devices Systems are expect......
  • Global Blood Glucose Testing Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 130
    According to our LPI (LP Information) latest study, the global Blood Glucose Testing market size was valued at US$ 10710 million in 2023. With growing demand in downstream market, the Blood Glucose Testing is forecast to a readjusted size of US$ 13370 million by 2030 with a CAGR of 3.2% during review period. The research report highlights the growth potential of the global Blood Glucose Testing market. Blood Glucose Testing are expected to show stable growth in the future market. However......
  • Global Lancing Devices Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117
    According to our LPI (LP Information) latest study, the global Lancing Devices market size was valued at US$ 315 million in 2023. With growing demand in downstream market, the Lancing Devices is forecast to a readjusted size of US$ 439.6 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Lancing Devices market. Lancing Devices are expected to show stable growth in the future market. However, product differentiation,......
  • Global Non-Invasive Glucose Meter Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Non-Invasive Glucose Meter market size was valued at US$ 175.6 million in 2023. With growing demand in downstream market, the Non-Invasive Glucose Meter is forecast to a readjusted size of US$ 268 million by 2030 with a CAGR of 6.2% during review period. The research report highlights the growth potential of the global Non-Invasive Glucose Meter market. Non-Invasive Glucose Meter are expected to show stable growth in the futu......
  • Global Glucose Meter Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Glucose Meter market size was valued at US$ 1258 million in 2023. With growing demand in downstream market, the Glucose Meter is forecast to a readjusted size of US$ 1959.5 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Glucose Meter market. Glucose Meter are expected to show stable growth in the future market. However, product differentiation, reduc......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs